Lindsay V. M. Leek

Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D‐CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials

R. Simes, P. Roepman, H. Gelderblom, 2023, International journal of cancer.

Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma

J. Haanen, V. Retèl, J. van de Haar, 2024, Scientific reports.